Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Shire PLC Add to portfolio

LON100:SHP, Aug 20, 04:51 UTC

Latest LON100:SHP News

Filter your feed

Apply Filter

Friday, August 09


News

Global Plasma Protease C1-inhibitor Treatment Market 2019 Shire plc, CSL Limited, Sanquin – Market Research News

SHP

Click sample pages of the report Plasma Protease C1-inhibitor Treatment at:www.extentresearch.com/request-for-sample.html?repid=9804. Table Of Contain in Report 15 Sections which Clarifies Global Plasma Protease C1-inhibitor Treatment Market Quickly are:. The main regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. 1- Plasma Protease C1-inhibitor Treatment Industry Overview 2- Region and Country Plasma Protease C1-inhibitor Treatment Market Analysis 3- Plasma Protease C1-inhibitor Treatment Technical Data and Manufacturing Plants Analysis 4- Production by Regions by Technology by Plasma Protease C1-inhibitor Treatment Applications 5- Plasma Protease C1-inhibitor Treatment Manufacturing Process and Cost Structure 6- Productions Supply Sales Demand Market Status and Plasma Protease C1-inhibitor Treatment Market Forecast 7- Key success factors and Plasma Protease C1-inhibitor Treatment Market Share Overview 8- Plasma Protease C1-inhibitor Treatment Research Methodology.

Read Full Details

Topics:
  • Business
  • Financial
  • Science
  • Health

Thursday, August 01


News

Global Coagulation Factors Market 2019 – Shire (Baxter), Bayer, CSL, Pfizer, Grifols – Rise Media

SHP

It focuses on critical and significant data which makes the research a very important tool for experts, analysts and managers to get ready-to-access analysis. Report provides inclusive analysis of Coagulation Factors market size development forecast from 2018-2025. Further, it provides their market share by various regions, with the company and product introduction and their position in Coagulation Factors market. There are 13 chapters to put on view for Coagulation Factors market: Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: Coagulation Factors Research Findings and Conclusion, Appendix, methodology and data source.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, July 31


News

Global Serum Albumin Market 2019 – Octapharma, Kedrion, CSL Behring, Shire (Baxter), Grifols – Rise Media

SHP

It focuses on critical and significant data which makes the research a very important tool for experts, analysts and managers to get ready-to-access analysis. Report provides inclusive analysis of Serum Albumin market size development forecast from 2018-2025. Further, it provides their market share by various regions, with the company and product introduction and their position in Serum Albumin market. There are 13 chapters to put on view for Serum Albumin market: Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: Serum Albumin Research Findings and Conclusion, Appendix, methodology and data source.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, July 17


News

Albumin Market to 2025 Status, Size and Scope by Leading Manufacturers- CSL Limited, Shire Plc, Grifols SA, Octapharma AG – Market Research Headlines

SHP

Albumin Market to 2025 Status, Size and Scope by Leading Manufacturers- CSL Limited, Shire Plc, Grifols SA, Octapharma AG. Albumin is one of the segments of blood plasma while the others are immunoglobulin, alpha1 and factor 8 proteins. Blood plasma Albumin is used for treating patients with blood related health issues such as hypoalbuminemia (low albumin), hypovolemic (low blood volume), acute respiratory distress syndrome (ARDS), burns, nephrosis, renal dialysis, acute liver failure, cardiopulmonary bypass surgery and hemolytic disease of the newborn. The report entitled “Global Albumin Market: Size, Trends & Forecasts (2018-2022)”, provides analysis of the global albumin market, with detailed analysis in terms of value, volume and per capita consumption of Albumin in various countries worldwide.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
  • Science

Tuesday, June 11


News

Changes to Kempsey Shire water supply source

SHP

Council's general manager Craig Milburn, said the flow levels in the Macleay River have dropped significantly in recent weeks and are now hovering around the trigger point for Level 3 water restrictions. "The cooler weather has resulted in a decline in algae growth that we've experienced in Steuart McIntyre Dam in the past and a return to normal water conditions," he said. Under the change, council will pump up to 8.5 megalitres a day from the Sherwood Borefield to top up the dam where the water will be treated before being distributed to reservoirs across the Shire. Council has a range of legislated enforceable measures available but is asking residents and business to adhere to the restrictions to help manage local water usage. For some handy tips for saving water in and around the home visit www.kempsey.nsw.gov.au/tips.

Read Full Details

Topics:
  • Business
  • Financial
  • Science

Friday, June 07


News

Global Peptide Based Gastrointestinal Disorders Therapeutics Market 2019 SWOT Analysis – Astellas Pharma, Allergan, Takeda Pharmaceutical, Shire – Market Reporter

SHP ABT +2 more SHP ABT ABBV AGN

Experts have analyzed the nature of development, investments in research and development, changing consumption patterns, and a growing number of applications. Moreover, data has been gathered from journals and market research experts to put together a document that sheds light on the ever-changing nature of market dynamics in an unbiased way. Fior Markets has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for world’s leading research professionals and agencies. Global Peptide Based Gastrointestinal Disorders Therapeutics Market 2019Global Peptide Based Gastrointestinal Disorders Therapeutics Market GrowthGlobal Peptide Based Gastrointestinal Disorders Therapeutics Market PriceGlobal Peptide Based Gastrointestinal Disorders Therapeutics Market ShareGlobal Peptide Based Gastrointestinal Disorders Therapeutics Market TrendsPeptide Based Gastrointestinal Disorders Therapeutics Market.

Read Full Details

Topics:
  • Business
  • Financial

Tuesday, May 21


News

May 21, 2019 - Trust Co Of Toledo Na Buys Cigna Corp, Andersons Inc, Takeda Pharmaceutical Co, Sells Farmers & Merchants Bancorp Inc, Cigna Corp, Shire PLC

SHP OXY +4 more SHP OXY BIIB LRCX BLK CI

Investment company Trust Co Of Toledo Na buys Cigna Corp, Andersons Inc, Takeda Pharmaceutical Co, Northrop Grumman Corp, Lam Research Corp, American Tower Corp, Facebook Inc, Northern Trust Corp, Consolidated Edison Inc, BlackRock Inc, New Senior Investment Group Inc, Occidental Petroleum Corp, CBL & Associates Properties Inc, Francescas Holdings Corp, Clean Energy Fuels Corp, sells Farmers & Merchants Bancorp Inc, Cigna Corp, Shire PLC, Phillips 66, Credit Acceptance Corp, Biogen Inc, MGIC Investment Corp, Darden Restaurants Inc, DTE Energy Co, Celgene Corp, BCE Inc, Accenture PLC, Philip Morris International Inc, PPL Corp during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Trust Co Of Toledo Na . As of 2019Q1, Trust Co Of Toledo Na owns 169 stocks with a total value of $305 million. Microsoft Corp (MSFT) - 137,495 shares, 5.31% of the total portfolio. Chevron Corp (CVX) - 59,832 shares, 2.41% of the total portfolio. Intel Corp (INTC) - 134,363 shares, 2.36% of the total portfolio.

Read Full Details

Topics:
  • Business
  • Financial

Thursday, May 16


News

May 16, 2019 - Teewinot Capital Advisers, L.L.C. Buys Facebook Inc, Bank of America Corporation, Citigroup Inc, Sells Pandora Media Inc, Delta Air Lines Inc, United Continental Holdings Inc

SHP DAL +16 more SHP DAL NXPI WFC 6758 STI FB MCRO C BAC UPS EA MPC GILD BKNG GS APTV LKQ

buys Facebook Inc, Bank of America Corporation, Citigroup Inc, Ryanair Holdings PLC, Spirit Airlines Inc, MGIC Investment Corp, sells Pandora Media Inc, Delta Air Lines Inc, United Continental Holdings Inc, Hertz Global Holdings Inc, Avis Budget Group Inc, Micro Focus International PLC during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Teewinot Capital Advisers, L.L.C.. As of 2019Q1, Teewinot Capital Advisers, L.L.C. Netflix Inc (NFLX) - 164,702 shares, 19.83% of the total portfolio. Controladora Vuela Compania de Aviacion SAB de CV (VLRS) - 4,710,804 shares, 13.55% of the total portfolio. Bank of America Corporation (BAC) - 1,136,016 shares, 10.59% of the total portfolio.

Read Full Details

Topics:
  • Business
  • Financial

Monday, May 13


News

Japan's Takeda expects annual loss on Shire deal

SHP

Visit our Privacy Policy to learn more or manage your personal preferences in our Cookie Consent Tool. May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar Shire deal. Japan's biggest drugmaker expects an operating loss of 193 billion yen ($1.76 billion) for the year to March 2020, compared with a 205 billion yen profit a year earlier. That compares with an average estimate for the current year of 227.5 billion yen profit from 12 analysts, compiled by Refinitiv.

Read Full Details

Topics:
  • Business
  • Financial

Friday, March 29


News

Agoraphobia Market Detailed Report With Growth Opportunity by Major Players - Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Pfizer, GlaxoSmithKline, Etc.

LLY SHP +6 more LLY SHP GSK BMY AZN PFE GSK AZN

Agoraphobia Market Detailed Report With Growth Opportunity by Major Players - Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Pfizer, GlaxoSmithKline, Etc. The report contains pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. The statistics are represented in graphical format for a clear understanding on facts and figures. For More Information On This Report, Please Visit www.upmarketresearch.com/home/enquiry_before_buying/85882.

Read Full Details

Story Sources

openpr.com openpr.com
Topics:
  • Business
  • Health
  • Financial
  • Science